Baxter buys British rival

America’s Baxter International yesterdfay said it would pay up to $330m (£219m) to acquire UK-based ApaTech, a privately held maker of biologics products used in orthopedic and dental surgeries. The agreement includes an upfront cash payment by Baxter of $240m, plus potential payments of up to $90m should the company achieve sales milestones. The transaction is expected to close in the first quarter.